Horizon’s Krystexxa (pegloticase) Receives the US FDA’s Approval and Expanding the Labeling for the Treatment of Uncontrolled Gout
Shots: The approval was based on the (MIRROR) trial evaluating Krystexxa + methotrexate vs Krystexxa & PBO in a ratio (2:1) in 152 adults with […]